Clinical Study Site 202 — Cullman, Alabama

Clinical Study Site 202 is a clinical research site located in Cullman, Alabama, United States 35055.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Clinical Study Site 202 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Obesity, Overweight, Weight Maintenance.

Sponsors: Verdiva Bio Dev Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cullman

Browse all research sites in Alabama · View every site in Cullman

• Cullman Clinical Trials
• Research Site
• North Central Neurology Associates PC
• North Central Neurology Associates
• Novartis Investigative Site
• North Central Neurology Associates, P.C.
• Alkermes Investigational Site
• Cullman Research Center
• Adamas Clinical Site
• Cullman Clinical Research, Inc
• AllerVie Clinical Research- Cullman
• Cullman Regional

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Study Site 202?

Clinical Study Site 202 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Study Site 202 conducted?

Clinical Study Site 202 has 1 clinical trials on record, with 1 currently active. Their work covers Obesity, Overweight, Weight Maintenance.

Is Clinical Study Site 202 accredited by Crixeo Clinical Trials?

Clinical Study Site 202 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Study Site 202?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.